Davide Bonazzi
Illustrator
From this contributor
Company on brink takes psilocybin to trial for fragile X syndrome
The phase 2A trial has its detractors despite positive animal results and is being sponsored by a company that is struggling financially.
Company on brink takes psilocybin to trial for fragile X syndrome
Explore more from The Transmitter
Romain Brette reveals fundamental flaws in commonly assumed neuroscience concepts
His new book, “The Brain, In Theory,” offers alternatives to many of the computer science frameworks currently driving theoretical neuroscience.
Romain Brette reveals fundamental flaws in commonly assumed neuroscience concepts
His new book, “The Brain, In Theory,” offers alternatives to many of the computer science frameworks currently driving theoretical neuroscience.
Arboreal deer mice reveal neural roots of dexterity
The rodents offered researchers an opportunity to link genetically driven changes in corticospinal abundance and morphology to climbing cachet.
Arboreal deer mice reveal neural roots of dexterity
The rodents offered researchers an opportunity to link genetically driven changes in corticospinal abundance and morphology to climbing cachet.
Single-gene systems-level effects, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 6 April.
Single-gene systems-level effects, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 6 April.